MSAC - Meeting 6-7 April 2017

Medical Services Advisory Committee - Applications Considered

• 1165.1 - Pre-implantation Genetic Diagnosis (PGD) Assessment – Resubmission
• 1216.1 - Cystic Fibrosis Transmembrane Regulator - Resubmission
• 1308 - Local Anaesthetic (LA) Nerve blockade for post-surgical analgesia
• 1331 - Review of archival tissue for further diagnostic testing
• 1360.1 - Specialist dermatology services delivered by asynchronous store and forward technology – Resubmission
• 1392 - Corneal Collagen Cross Linking as early intervention in progressive keratoconus
• 1397 - mpMRI prostate diagnostic scans
• 1422 - Minimally invasive, lumbar decompression and dynamic stabilisation using an interlaminar device, with no rigid fixation to the vertebral pedicles, implantation between the spinous processes of one or two lumbar motion segments
• 1424 - MR guided biopsy procedures for diagnosis of prostate cancer
• 1429 - Intraoperative Radiotherapy for Early Stage Breast Cancer
• 1432 - Magnetic resonance imaging of patients with suspected non-ischaemic cardiomyopathies
• 1440 - PD-L1 testing for access to pembrolizumab in treatment naive patients with locally advanced or metastatic non-small cell lung cancer
• 1443 - Implantable loop recorders for diagnosis of atrial fibrillation in cryptogenic stroke
• 1456 - 17p Deletion Testing for Access to Venetoclax in Patients with Relapsed/Refractory Chronic Lymphoid Leukaemia
• 1479r - Substitution of Ga-68-DOTA peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369